12 - IRSA - Cnr

Fig. 2 - Tipico cromatogramma ottenuto analizzando
un’acqua superficiale (fiume Tevere) con rivelatori UV e
fluorescenza (FL). 1: Carbamazepina; 3: Ketoprofene;
5: Naproxene; 9: Diclofenac; 10: Ibuprofene; 11:
Gemfibrozil.
BIBLIOGRAFIA
BAKER D.R., KASPRZYK-HORDERN B. (2011):
“Critical evaluation of methodology commonly used
in a sample collection, storage and preparation for
the analysis of pharmaceuticals and illicit drugs in
surface water and wastewater by solid phase
extraction and liquid chromatography-mass
spectrometry”, J. Chromatogr. A., 1218, 7901-7913.
BOTTONI P., BARRA CARACCIOLO A. (2010):
“Pharmaceutical as priority water contaminants”,
Toxicol. Environ. Chem., 92, 549-565.
CASTIGLIONI S., FANELLI R., CALAMARI D.,
BAGNATI R., ZUCCATO E. (2004): ”Methodological
approaches for studying pharmaceuticals in the
environment by comparing predicted and measured
concentrations in River Po, Italy”, Regul. Toxicol.
Pharmacol., 39, 25-32.
Notiziario dei Metodi Analitici
35
n.1 (2012)
Fig. 3 - Tipico cromatogramma ottenuto analizzando un
effluente con rivelatori UV e fluorescenza (FL). 1:
Carbamazepina; 3: Ketoprofene; 5: Naproxene; 9:
Diclofenac; 10: Ibuprofene; 11: Gemfibrozil.
EUROPEAN MEDICINES AGENCY/COMMITTEE
for MEDICINAL PRODUCTS for HUMAN USE
(EMEA/CHMP) (2006): “Guideline on the
environmental risk assessment of medicinal
products for human use”, London, UK, EMEA,
EMEA/CHMP/SWP/4447/00.
FENT K., WESTON A.A., CAMINADA D. (2006):
“Review ecotoxicology of human pharmaceuticals”,
Aquat. Toxicol., 76, 122-159.
GONZÀLEZ ALONSO S., CATALÀ M., MAROTO
R.R., RODRÌGUEZ GIL J.L., GIL DE MIGUEL A.,
VALCÀRCEL Y. (2010): “Pollution by psychoactive
pharmaceuticals in the Rivers of Madrid
metropolitan area (Spain)”, Environ. Intern., 36, 195-
201.